Literature DB >> 12601315

Partial laryngectomy after irradiation failure.

John Yiotakis1, Pelagia Stavroulaki, Thomas Nikolopoulos, Leonidas Manolopoulos, Dimitrios Kandiloros, Eletherios Ferekidis, George Adamopoulos.   

Abstract

INTRODUCTION: Radiation therapy is often the first method of treating patients with early cancer of the glottis. There is a substantial failure rate among these patients. Total laryngectomy has usually been the means of treating patients with failure after radiation. In recent decades, partial laryngectomy has been used for salvage in such patients. This article will discuss the use of partial laryngectomy for radiation failure both from the oncologic result as well as the morbidity. PATIENTS AND METHODS: Between 1984 and 1995, 27 patients with early-stage laryngeal carcinoma underwent salvage partial laryngectomy after irradiation failure. Vertical laryngectomy was performed in 18 patients (13 with T1 N0 and 5 with T2 N0) and horizontal-supraglottic laryngectomy in 9 patients (3 with T1 N0, 1 with T2 N0, and 5 with T2 N1). The mean follow-up was 4.1 years.
RESULTS: Local control was obtained in 77.7% of patients with glottic lesions (T1: 84.6%; T2: 60%, P = NS) and in 55.5% of patients with supraglottic lesions (T1: 66.6%; T2: 50%; P = NS). There was no regional recurrence in the vertical laryngectomy group, whereas the regional control rate in the horizontal-supraglottic laryngectomy group was 77.7%. Distant control was achieved in 94.4% of patients with glottic disease and in 77.7% of patients with supraglottic disease. The overall survival rate for glottic lesions was 88.8% (T1: 92.3%; T2: 80%; P = NS) versus 66.6% for supraglottic lesions (T1: 100%; T2: 50%; P = NS). CONCLUSION AND SIGNIFICANCE: Vertical laryngectomy was not associated with an increased complication rate. Morbidity in the horizontal-supraglottic laryngectomy group was higher, but a satisfactory functional outcome was obtained in all cases. Therefore, in early laryngeal cancer (glottic T1-T2, supraglottic T1) partial laryngectomy can be performed with good expectation of cure and satisfactory laryngeal function. In T2 supraglottic lesions, the oncologic results are less satisfactory; further research is required for developing more efficient complimentary or alternative treatments modalities.

Entities:  

Mesh:

Year:  2003        PMID: 12601315     DOI: 10.1067/mhn.2003.63

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  Laryngectomy-free survival after salvage partial laryngectomy: a systematic review and meta-analysis.

Authors:  Udi Shapira; Anton Warshavsky; Nidal Muhanna; Yael Oestreicher-Kedem; Yuval Nachalon; Omer J Ungar; Ahmad Safadi; Narin N Carmel Neiderman; Gilad Horowitz
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-17       Impact factor: 2.503

Review 2.  Supracricoid laryngectomy for recurrent laryngeal cancer after chemoradiotherapy: a systematic review and meta-analysis.

Authors:  C A Leone; P Capasso; D Topazio; G Russo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-12       Impact factor: 2.124

3.  Correlation of alterations in the KEAP1/CUL3/NFE2L2 pathway with radiation failure in larynx squamous cell carcinoma.

Authors:  Siddharth Sheth; Douglas R Farquhar; Travis P Schrank; Wesley Stepp; Angela Mazul; Michele Hayward; Nicholas Lenze; Paul Little; Heejoon Jo; M Ben Major; Bhishamjit S Chera; Jose P Zevallos; D Neil Hayes
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-06-03

Review 4.  Organ preservation surgery for laryngeal cancer.

Authors:  Sharad Chawla; Andrew Simon Carney
Journal:  Head Neck Oncol       Date:  2009-05-15

5.  Transoral laser surgery for recurrent glottic cancer after radiotherapy: oncologic and functional outcomes.

Authors:  F Del Bon; C Piazza; S Mangili; L O Redaelli De Zinis; P Nicolai; G Peretti
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-08       Impact factor: 2.124

6.  [Supracricoid partial laryngectomy (SCPL) with either cricohyoidoepiglottopexy (CHEP): our experience with 16 cases].

Authors:  Bouchaib Hemmaoui; Mohamed Sahli; Noureddine Errami; Ahmed Rouihi; Mohamed Habib Bahalou; Ilias Benchaifai; Amine Ennouali; Sara Britel; Ismail Nakkabi; Ali Jahidi; Mohamed Zalagh; Saloua Ouaraini; Fouad Benariba
Journal:  Pan Afr Med J       Date:  2017-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.